𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Transforming growth factor-β1 modulates adenylyl cyclase signaling elements and epidermal growth factor signaling in cardiomyocytes

✍ Scribed by Bipin G. Nair; Yiming Yu; Hani M. Rashed; Hui Sun; Tarun B. Patel


Publisher
John Wiley and Sons
Year
1995
Tongue
English
Weight
898 KB
Volume
164
Category
Article
ISSN
0021-9541

No coin nor oath required. For personal study only.

✦ Synopsis


Studies presented in this report were designed to investigate the effects of transforming growth factor-pl (TGF-01) on epidermal growth factor (EGF)mediated stimulation of CAMP accumulation in cardiac myocytes and elucidate the mechanism(s) involved in this modulation. TGF-PI (20 pM) treatment of cardiac myocytes, in a time-dependent manner, decreased the ability of EGF (100 nM) to increase CAMP accumulation. Significant attenuation of EGFelicited CAMP accumulation was observed 2 h after exposure to TGF-PI and 18 h after addition of TGF-p1, the ability of EGF to increase CAMP accumulation was completely obliterated. TGF-P1 neither decreased immunoprecipitable EGF receptors in membranes from cardiomyocytes nor altered the specific binding of [ "'IIEGF to cardiomyocyte membranes. However, TGF-Pl decreased the ability of EGF to phosphorylate membrane proteins on tyrosine residues. TGF-Pl treatment of cardiomyocytes also decreased the ability of forskolin to augment CAMP accumulation in intact cells and stimulate adenylyl cyclase activity. Similarly, in membranes of TGF-P1 -treated cells, neither isoproterenol nor EGF stimulated adenylyl cyclase activity. Interestingly, as assessed by the ability of A1 F,to stimulate adenylyl cyclase, TGF-P1 did not alter the coupling between G, and catalytic subunits. Likewise, TGF-Pl did not alter the functional activity of the inhibitory regulatory element of the system, G,. Western analysis of cellular proteins revealed that TGF-P1 did not alter the amounts of G,,, G,,,, and G,, %. We conclude that TGF-P1 attenuates EGF-elicited CAMP accumulation in cardiomyocytes, in part, by decreasing the EGF receptor kinase function and that TGF-P1 -mt,diated alterations in the activity of adenylyl cyclase catalytic subunit also contribute toward the regulation of adenylyl cyclase by various agonists.


📜 SIMILAR VOLUMES


Transforming growth factor-β signaling i
✍ Suvi-Katri Leivonen; Veli-Matti Kähäri 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 229 KB

## Abstract Transforming growth factor‐β (TGF‐β) family members are polypeptides with dual tumor suppressive and oncogenic effects. They signal through serine/threonine kinase receptor complexes, which phosphorylate cytoplasmic mediators, the Smads. Upon phosphorylation, Smads translocate to the nu

The tetraspanin CD9 modulates epidermal
✍ Yoko Murayama; Yasuhisa Shinomura; Kenji Oritani; Jun-Ichiro Miyagawa; Hitoshi Y 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 502 KB

## Abstract CD9 is a member of the tetraspanins, and has been shown to be involved in a variety of cellular activities such as migration, proliferation, and adhesion. In addition, it has been known that CD9 can associate with other proteins. Here we demonstrated the physical and functional associat

Disrupted transforming growth factor-β s
✍ Shujiro Yazumi; Kohaku Ko; Norihiko Watanabe; Hisashi Shinohara; Kiyotsugu Yoshi 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 714 KB

Biliary tract carcinoma is a common neoplasm in Japan, and its treatment is difficult because it tends to promote fibrosis and easily invades surrounding tissues. To better characterize the biological features of this carcinoma, we investigated abnormalities in the transforming growth factor-␤ (TGF-